Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Gastrointestinal Cancer
Published in: Journal of Gastrointestinal Cancer 1/2020

01-03-2020 | Gastrointestinal Stromal Tumor | Case Report

A Case Report of a Right Mesocolon Solitary Fibrosis Tumour

Authors: Mohamed Ali Chaouch, Hichem Jerraya, Mohamed Wejih Dougaz, Nabil Haloui, Ibtissem Bouasker, Ramzi Nouira

Published in: Journal of Gastrointestinal Cancer | Issue 1/2020

Login to get access

Excerpt

Malignant solitary fibrous tumour (SFT) is a rare mesenchymal tumour which can develop at any part of the body [1]. Generally, it is benign but 13 to 23% of reported cases were malignant [1]. The clinical signs are often rough because of the slowness of evolution. The rarity of abdominal localization and the absence of specific signs make diagnosis difficult to rise preoperatively. The purpose of this paper is to report a new case of a malignant SFT originated from the right mesocolon discovered incidentally and mimicking a gastrointestinal stromal tumour (GIST) in abdominal CT scan. …
Literature
1.
Hanau CA, Miettinen M. Solitary fibrous tumor: histological and immunohistochemical spectrum of benign and malignant variants presenting at different sites. Hum Pathol. 1995;26(4):440–9.CrossRef
2.
Chan JKC. Solitary fibrous tumour—everywhere, and a diagnosis in vogue. Histopathology. 1997;31(6):568–76.CrossRef
3.
Cotterill AM, et al. The insulin-like growth factors and their binding proteins in a case of non-islet-cell tumour-associated hypoglycaemia. J Endocrinol. 1991;131.2:303–11.CrossRef
4.
Shidham VB, et al. Immunohistochemical comparison of gastrointestinal stromal tumor and solitary fibrous tumor. Arch Pathol Lab Med. 2002;126.10:1189–92.
5.
Fatima N, Cohen C, Siddiqui MT. DOG1 utility in diagnosing gastrointestinal stromal tumors on fine-needle aspiration. Cancer Cytopathol. 2011;119(3):202–8.CrossRef
6.
England DM, Hochholzer L, McCarthy MJ. Localized benign and malignant fibrous tumors of the pleura. A clinicopathologic review of 223 cases. Am J Surg Pathol. 1989;13(8):640–58.CrossRef
7.
Ginat DT, Bokhari A, Bhatt S, Dogra V. Imaging features of solitary fibrous tumors. Am J Roentgenol. 2011;196(3):487–95.CrossRef
8.
Bhat A, et al. Solitary fibrous tumor of the ischioanal fossa—a multidisciplinary approach to management with radiologic-pathologic correlation. Radiol Case Rep. 2018;13.2:468–74.CrossRef
9.
Fujiwara-Tani R, et al. “A case of a malignant solitary fibrous tumor in the maxillary sinus extending into the intracranial space.” Review and Reports Press. 2018;84–86.
10.
Levy AD, et al. Benign fibrous tumors and tumorlike lesions of the mesentery: radiologic-pathologic correlation. Radiographics. 2006;26.1:245–64.CrossRef
11.
Park MS, et al. Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor. Cancer. 2011;117.21:4939–47.CrossRef
Metadata
Title
A Case Report of a Right Mesocolon Solitary Fibrosis Tumour
Authors
Mohamed Ali Chaouch
Hichem Jerraya
Mohamed Wejih Dougaz
Nabil Haloui
Ibtissem Bouasker
Ramzi Nouira
Publication date
01-03-2020
Publisher
Springer US
Published in
Journal of Gastrointestinal Cancer / Issue 1/2020
Print ISSN: 1941-6628
Electronic ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-019-00294-x

Other articles of this Issue 1/2020

Journal of Gastrointestinal Cancer 1/2020 Go to the issue

Original Research

The First Screening Program for Colorectal Cancer in the North of Iran

Case Report

Liver Transplantation for High-Grade Primary Hepatic Neuroendocrine Tumor with Diffuse Liver Metastasis

Original Research

Treatment Patterns and Economic Burden by Lines of Therapy Among Patients with Advanced Hepatocellular Carcinoma Treated with Systemic Cancer Therapy

Original Research

Association of High Expression Levels of SOX2, NANOG, and OCT4 in Gastric Cancer Tumor Tissues with Progression and Poor Prognosis

Original Research

Surgery for Locally Advanced GIT Cancers Has Potentially Good Postoperative Outcomes in a Tertiary Hospital

Case Report

Metastatic Signet Ring Cell Carcinoma of the Ampulla of Vater with an Unusually Prolonged Survival
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits